Latest Medical News: mRNA Vaccine Shows Promise in Cancer Treatment
According to a paper published in Nature, a personalized cancer vaccine using the mRNA platform showed positive results in a Phase 2 clinical trial.
In an experiment targeting melanoma patients, it reduced the recurrence rate by 44% compared to existing immunotherapy. Although it has not yet been approved, the potential of the technology seems significant. Related research is also underway in Korea, but we'll have to wait and see.
10 answers
Do you have a source? Could you tell me the title of a Nature paper?
Oh, I'm looking forward to this lol. mRNA for cancer treatment, huh?
I heard they're doing research in Korea—is it at Samsung Hospital? Does anyone know?
It's quite promising for Phase 2, but there's still a long way to go, right? There are many cases where it fails in Phase 3.
This is right lol. I went to a related seminar before, and the technology is really innovative. But the price is the problem...
I have an acquaintance who received immunotherapy before, and they were so terrified of recurrence... I really hope this technology gets commercialized soon.
Is that from Nature Medicine? I found the correct paper. The data itself is definitely positive. However, the sample size is small, so we need to keep an eye on it.
Agreed. Since it's personalized, side effects are likely fewer.
Disagree. mRNA vaccines themselves haven't yet been verified for long-term safety, so applying them to cancer seems too hasty. We need to gather more data first.
But melanoma is known to respond well to immunotherapy, so it's uncertain whether this applies to other cancers. Isn't that a bit too optimistic?